Maurice Cary

DVM, PhD, Diplomate ACVP, Pre-clinical Expert

Co-founder & Senior Partner XOventure

A diplomate of the American College of Veterinary Pathologists since 1989, Maurice received his Doctor of Veterinary Medicine degree from Tuskegee University (USA) in 1980 and his PhD in veterinary pathology (toxicologic) from Washington State University in 1985. There he also completed the pathology residency program (Washington Animal Disease Diagnostic Laboratory). 

In 1985 Maurice accepted a Post-Doctoral Fellowship in Research Pathology at Schering-Plough Pharmaceuticals (New Jersey). In 1986, he was employed as a Senior Pathologist by Schering-Plough. In 1988 he joined Ciba-Geigy, where he served as Senior Pathologist. After a one-year exchange working at Ciba-Geigy's Basel (Switzerland) site as a Pathologist in 1991, Maurice was hired by Sandoz Pharmaceuticals (Basel) as Head of Pathology in 1993. After the merger to form Novartis (1996), Maurice became Head of Contracting/Outsourcing for Toxicology with overall outsourcing responsibility for Novartis in Europe. 

In 2000 he founded Cary Consulting (Switzerland), with focus on e.g.  placing and monitoring studies in CROs, report preparation and review, regulatory document preparation, histopathology, and advising companies on compound development and strategies. Maurice served as liaison for the Society of Toxicologic Pathologists (STP) to the European Society of Toxicology (1995-1998) and is since 2005 on the editorial board of “Toxicology Pathology”. He is founder and CEO of Pathology Experts (Switzerland), a team of highly qualified senior level Toxicologic Pathologists, and involved as expert in many of the service areas offered by the Company.